Faslodex is used for the treatment of hormone receptor-positive metastatic breast cancer found in postmenopausal women.
Faslodex is the trade name for Fulvestrant. In some cases, health care professionals may use the trade name Faslodex when referring to the generic drug name Fulvestrant.
Drug type: Faslodex is a hormone therapy. It fights cancer as an estrogen receptor down-regulator.
It is used to treat estrogen receptor positive metastatic breast cancer (cancer that has spread) in postmenopausal women, with disease progression following antiestrogen therapy. It is manufactured by AstraZeneca Pharmaceuticals